IRIS
SCHIRINZI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.669
AS - Asia 3.334
EU - Europa 2.325
SA - Sud America 527
AF - Africa 61
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.546
SG - Singapore 1.622
IT - Italia 779
CN - Cina 538
BR - Brasile 423
RU - Federazione Russa 361
HK - Hong Kong 330
VN - Vietnam 273
IE - Irlanda 211
DE - Germania 187
KR - Corea 185
UA - Ucraina 133
GB - Regno Unito 129
FR - Francia 123
JP - Giappone 115
NL - Olanda 87
FI - Finlandia 79
CA - Canada 68
IN - India 66
SE - Svezia 61
PL - Polonia 46
AR - Argentina 44
BD - Bangladesh 39
MX - Messico 36
AT - Austria 34
ID - Indonesia 32
ZA - Sudafrica 29
IQ - Iraq 20
TR - Turchia 20
EC - Ecuador 18
ES - Italia 17
JO - Giordania 16
AL - Albania 10
CH - Svizzera 10
BE - Belgio 9
CO - Colombia 9
VE - Venezuela 9
KG - Kirghizistan 8
LT - Lituania 8
MA - Marocco 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
TH - Thailandia 6
AU - Australia 5
CL - Cile 5
EG - Egitto 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
RS - Serbia 5
TN - Tunisia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
NP - Nepal 4
AZ - Azerbaigian 3
BO - Bolivia 3
HN - Honduras 3
MY - Malesia 3
CR - Costa Rica 2
GE - Georgia 2
JM - Giamaica 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
GA - Gabon 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 20.924
Salva come PNG Salva come JPEG
Città #
Wilmington 3.522
Houston 3.121
Woodbridge 2.641
Singapore 882
Fairfield 534
Ashburn 483
San Jose 388
Chandler 363
Hong Kong 327
Rome 245
Ann Arbor 231
Seattle 227
Beijing 195
Cambridge 187
Dublin 184
New York 139
Santa Clara 133
The Dalles 131
Medford 129
Council Bluffs 119
Dallas 118
Tokyo 113
Dearborn 110
Los Angeles 95
Jacksonville 91
Hanoi 86
Ho Chi Minh City 80
Milan 73
Lawrence 61
Lauterbourg 58
Buffalo 57
North Bergen 55
São Paulo 46
Menlo Park 45
Moscow 41
Helsinki 39
Munich 37
Orem 32
London 29
Chicago 28
Nuremberg 28
Montreal 26
Brooklyn 24
Redondo Beach 24
Toronto 24
Warsaw 24
Johannesburg 21
San Diego 21
Phoenix 20
Stockholm 20
Chennai 19
Frankfurt am Main 19
Denver 18
Kraków 18
Mexico City 18
Zhengzhou 18
Shenzhen 17
Amsterdam 16
Nanjing 16
Shanghai 16
Amman 15
Jakarta 15
Norwalk 15
Seoul 15
Boardman 14
Boston 14
Colorado Springs 14
Lappeenranta 14
Kunming 13
Manchester 13
Poplar 13
Atlanta 12
Del Norte 12
Hefei 12
Monmouth Junction 12
Vienna 12
Incheon 11
Rio de Janeiro 11
Creede 10
Da Nang 10
Durham 10
Guangzhou 10
Mountain View 10
Paris 10
Salt Lake City 10
Verona 10
Belo Horizonte 9
Columbus 9
Naples 9
Newham 9
Salvador 9
Bologna 8
Brussels 8
Detroit 8
Florence 8
Guarulhos 8
Redwood City 8
Tashkent 8
Bari 7
Center 7
Totale 16.314
Salva come PNG Salva come JPEG
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 622
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 504
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 489
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 479
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 463
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 454
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 447
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 441
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 439
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 438
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 433
Centrality of striatal cholinergic transmission in Basal Ganglia function 432
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 429
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 427
Double hit mouse model of Parkinson's disease 425
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 424
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 408
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 401
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 396
Centrality of early synaptopathy in Parkinson's disease 378
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 369
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 349
Dopaminergic involvement in a drummer with focal dystonia: A case study 323
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 320
Promising rodent models in Parkinson's disease 318
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 306
Assessment of serum uric acid as risk factor for tauopathies 303
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 298
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 275
Long-term treatment with rotigotine in drug-naïve PSP patients 274
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 269
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 267
The effect of postural deformities on back function and pain in patients with Parkinson's disease 261
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 255
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 255
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 247
Dystonia as a network disorder: A concept in evolution 238
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 236
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 215
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 209
Systemic activation of Nrf2 pathway in Parkinson's disease 194
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 191
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 183
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 183
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 173
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 170
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 169
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 160
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 150
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 149
Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study 139
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 129
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 128
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 128
Spinal vascular lesions: anatomy, imaging techniques and treatment 121
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 111
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 106
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 103
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 102
Axial postural abnormalities and pain in Parkinson's disease 102
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 101
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 101
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 100
Clinical course of paroxysmal dyskinesias throughout pregnancy 99
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 97
Validation of the Italian version of the PSP Quality of Life questionnaire 97
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 97
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson's disease 95
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 94
COVID-19: dealing with a potential risk factor for chronic neurological disorders 94
Early Alterations in De Novo Parkinson’s Disease Revealed by Diffusion Tensor Imaging: Preliminary Study 90
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 90
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 89
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 88
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 88
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 88
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 85
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 85
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 84
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 82
Short‐Term Effects of Continuous Theta Burst Stimulation in Treating a Young Patient Affected by Post‐Ischemic Hemidystonia 82
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 81
A biological characterization of patients with postmenopausal Parkinson's disease 78
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 78
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 77
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 76
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 76
Biofluids profile of ?-Klotho in patients with Parkinson{'}s disease 75
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 74
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients 74
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 74
Gastrointestinal Dysfunction Bears on the Clinical‐Biological Profile of Parkinson's Disease 74
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 73
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 73
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease 69
Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus 69
Using a Video Device and a Deep Learning-Based Pose Estimator to Assess Gait Impairment in Neurodegenerative Related Disorders: A Pilot Study 68
Prevenzione del rischio di disturbo muscoloscheletrico in lavoratori videoterminalisti affetti da Malattia di Parkinson. Studio ergonomico e riabilitativo 67
Oral Health and Use of Novel Transbuccal Drug Delivery Systems in Patients with Alzheimer’s and Parkinson’s Disease: A Review 64
Effects of head trauma and sport participation in young-onset Parkinson?s disease 64
Totale 20.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 0 96 29
2021/2022793 31 61 60 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20252.790 58 505 224 146 86 279 193 227 239 292 312 229
2025/20264.784 392 191 595 426 454 207 627 637 517 634 104 0
Totale 21.490